Are They Risk Takers? It's Time to Turn Boomers into Healthy Zoomers



    
    -   Zoomers say jumping out of a plane is riskier than avoiding
        cholesterol and blood pressure testing - 65 per cent of Zoomers view
        skydiving as highly risky, versus 53 per cent who don't see the high
        risk in avoiding cholesterol and blood pressure checks
    -   Zoomers are buckling up ... but not to go to the doctor - the vast
        majority (85 per cent) of Zoomers regularly wear a seat belt, yet
        only 60 per cent regularly visit a doctor for an annual check-up
    -   And what's up with Zoomers not taking their meds? - 30 per cent of
        Zoomers regularly or occasionally forget to take medication
        prescribed by a doctor, but only 60 per cent believe that this is a
        high risk behaviour
    

    TORONTO, Oct. 30 /CNW/ - According to the international "Are You a Risk
Taker?" survey, which examined perceptions, experiences and recognition of
risky behaviours among people aged 40+, Canadian Zoomers (Boomers with zip)
appear to be taking some age-related medical risks that could put their daily
lives in jeopardy. The results of the Canadian data were announced today by
ASPIRIN(R) 81mg, the title sponsor of the inaugural ZoomerShow this weekend in
Toronto.
    "There are a lot of Zoomers out there risking their health," says
Dr. Akbar Panju, CARP (Canada's Association for the 50+) Conference keynote
speaker and Division Director, General Internal Medicine at Hamilton's
McMaster University. "These results should be a wake-up call; Zoomers can't
overlook the important simple and manageable lifestyle choices that emphasize
good health and well-being that may lessen their health risks."
    Not wearing a seatbelt (65%) is viewed by a higher proportion of
consumers as high risk than not taking prescribed medication (60%), not going
to a doctor for annual check-ups (38%) and not exercising regularly (31%).
    In addition, although the survey shows that 60 per cent of Canadians say
they are not risk takers with their personal health, 51 per cent of these
people routinely engage in two or more risky health behaviours.
    "Zoomers can incorporate simple, manageable lifestyle choices and consult
their doctor about taking ASPIRIN(R) 81 mg as a daily preventative therapy.
It's time for Canadians to recognize the actual risks they're taking with
their health behaviours and choose to be proactive when it comes to their
overall health," said Dr. Panju. "Zoomers are a vital, active group, but they
need to pay better attention to health risks the same way they understand the
importance of wearing a seatbelt."

    ABOUT ASPIRIN(R) 81MG

    ASPIRIN(R) 81 mg is recommended for doctor supervised daily preventative
therapy.

    ABOUT THE SURVEY

    The research data from "Are You a Risk Taker?" survey represents key
findings from an online survey of 301 Canadian adults, 40 years of age or
older. The survey was administered by GMI using its online panel of consumers
in Canada. The distribution of respondents reflects the age and gender profile
of the population of Canada who are now 40 years of age or older. The study
was conducted in May 2008.

    About Bayer Inc.

    Bayer Inc. (Bayer) is a Canadian subsidiary of Bayer AG, an international
research-based group with core businesses in health care, crop science, and
innovative materials.
    Headquartered in Toronto, Ontario, Bayer Inc. operates the Bayer Group's
HealthCare and MaterialScience businesses in Canada. Bayer Crop Science Inc.,
headquartered in Calgary, Alberta operates as a separate legal entity in
Canada. Together, the companies play a vital role in improving the quality of
life for Canadians - producing products that fight diseases, protecting crops
and animals, and developing high-performance materials for applications in
numerous areas of daily life. Canadian Bayer facilities include the Toronto
headquarters and offices in Ottawa and Calgary.
    Bayer Inc. has approximately 1,000 employees across Canada and had sales
of over $986 million CDN in 2007. Globally, the Bayer Group had sales of over
32 billion Euro in 2007. Bayer Inc. invested approximately $45 million CDN in
research and development in 2007. Worldwide, the Bayer Group spends the
equivalent of over 2.5 billion Euro in 2007 in R&D.

    Forward-looking statements

    This release may contain forward-looking statements based on current
assumptions and forecasts made by Bayer Group or subgroup management. Various
known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. These
factors include those discussed in Bayer's public reports which are available
on the Bayer website at www.bayer.com. The company assumes no liability
whatsoever to update these forward-looking statements or to conform them to
future events or developments.

    
    References:
    1.  World Heart Federation. Available at
        http://www.world-heart-federation.org/cardiovascular-health/.
        Sourced on September 30, 2008

    2.  Heart and Stroke Foundation of Canada. Available at
        http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3479073/k.99CA/Fun
        ded_Research.htm.
        Sourced on September 30, 2008
    





For further information:

For further information: Collin Matanowitsch, MS&L, (416) 847-1330,
collin.matanowitsch@mslworldwide.com

Organization Profile

Bayer HealthCare

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890